Brief: Obseva Posts Data Showing Efficacy Of Linzagolix In Potential New Indication For Treatment Of Adenomyosis
04/06/2020 06:04
June 4 (Reuters) - OBSEVA SA OBSN.S :
* ANNOUNCES PUBLICATION OF DATA SHOWING EFFICACY OF
LINZAGOLIX IN
A POTENTIAL NEW INDICATION FOR TREATMENT OF ADENOMYOSIS
Source text for Eikon: ID:nGNE6626H5
Further company coverage: OBSN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Obseva SA
See all newsBrief: Obseva Announces Wind-Down Of Operations And Likely Not Going To Be Able To Satisfy Requirements For Maintaining Its Listing
Brief: Obseva Applies For Moratorium To Facilitate Pivotal Deals
Brief: Obseva SA Says Xoma Will Receive Full Worldwide Rights On Ebopiprant Following Termination Of License Agreement With Organon
Brief: Obseva Appoints Fabien De Ladonchamps As Chief Executive Officer Effective May 1, 2023
Brief: Obseva Announces Change Of Central Securities Depositary